The NHS is grappling with a severe crisis in cancer care as a shortage of staff threatens the timely treatment of patients, according to senior medical professionals. While advancements in cancer treatment have led to a significant increase in survival rates, the system is struggling to keep pace with the growing number of diagnoses, which have surged to over 354,820 since the pandemic. As the government prepares to unveil a comprehensive 10-year strategy to overhaul cancer services, experts are sounding alarms about the dire implications of staff shortages on patient outcomes.
Rising Diagnoses and Delayed Treatments
Recent analysis by Cancer Research UK reveals that the NHS is failing to meet its target of treating 85% of cancer patients within 62 days of their urgent referral. In 2025, approximately 100,000 patients waited longer than the recommended period, with only 70% receiving treatment in the designated timeframe. This backlog has significant consequences, as many patients may face the progression of their cancer, necessitating more aggressive therapies and further straining an already stretched healthcare system.
Dr Nicky Thorp, Vice-President of the Royal College of Radiologists, expressed grave concerns about the current situation, stating, “This is a potential disaster, creating bottlenecks in our services. We have qualified staff ready to fill positions, yet they are unable to find employment.” The NHS aims to achieve equitable access to life-saving treatments, yet the reality on the ground paints a worrying picture.
Government’s Planned Response
On Wednesday, the government is expected to announce its ambitious 10-year plan aimed at revitalising cancer services across England. This strategy will include commitments to meet all NHS cancer waiting time targets by 2029 and enhance access to advanced treatments such as robot-assisted surgery and genomic testing. However, experts argue that without sufficient staffing and resources, these pledges may remain unfulfilled.
Current data highlights a pressing need for increased personnel, with the Royal College of Radiologists estimating a shortfall of nearly 2,000 doctors, which could escalate to over 3,600 by 2029. The situation is compounded by budget constraints that have led to hiring freezes, further exacerbating staffing shortages and impacting patient care.
The latest statistics show an alarming trend: the number of diagnoses for common cancers, including breast, prostate, lung, and bowel cancer, has markedly increased over the past decade. For instance, breast cancer diagnoses rose to over 50,500 in 2023, with significant numbers of patients presenting at more advanced stages.
The Human Cost of Delays
The repercussions of these delays are profoundly distressing for patients and their families. Dr Andrew Wardley, president of the Association of Cancer Physicians, recounted the experiences of patients waiting weeks for crucial diagnostic tests like the HER2 test, which determines treatment options for aggressive breast cancer. He emphasised the emotional toll this takes on individuals already facing the daunting reality of a cancer diagnosis.
“Patients are not only delayed in receiving their treatments, but they are also left in limbo, worrying about their health,” Wardley noted. “The current situation is untenable and places an undue burden on both patients and healthcare providers.”
Additionally, screening rates for breast cancer among women over 50 have dropped from 74% in 2019 to 70% in 2024, signalling a worrying trend that could lead to more advanced cases going undetected.
A Call to Action
The challenges facing the NHS in delivering timely cancer care are multifaceted, stemming from both staffing shortages and an increasing patient population. While the government’s forthcoming plan holds promise, many experts stress that immediate action is necessary to alleviate the pressures on the system.
Angela Waters, a breast reconstruction surgeon in Birmingham, highlighted the disparity in service availability, stating, “We are overwhelmed with demand, and some regions have very limited access to crucial treatments. It’s an unfair situation.”
Dr Nicky Thorp reiterated the need for urgent reforms, urging that “if we truly wish to improve cancer care, we cannot ignore the need for adequate staffing and funding.”
Why it Matters
The implications of this crisis extend far beyond the realm of healthcare; they resonate deeply within communities and families across the UK. As cancer remains one of the leading causes of mortality, timely access to effective treatment is not merely a matter of policy but of human dignity and life itself. Without urgent intervention to address staffing shortages and enhance resources, the NHS risks compromising the very lives it seeks to protect, leaving thousands of patients vulnerable at a critical juncture in their treatment journey.
